Background: Hypoattenuated leaflet thickening (HALT), identified on functional cardiac
computed tomography (CTA), can affect valve function and clinical outcomes. The objective of …

Background We previously reported high in-hospital mortality for ST-segment elevation
myocardial infarction (STEMI) patients with COVID-19 treated in the early phase of the pandemic. …

Background Contemporary real‐world data on stroke in patients presenting with ST‐segment–elevation
myocardial infarction (STEMI) are scarce. Methods and Results We evaluated …

Background: High-sensitivity cardiac troponin (hs-cTn) laboratory assays are used to rule out
myocardial infarction (MI) on presentation, but prolonged result turnaround times can delay …

Background We evaluated the diagnostic performance of a whole blood, point of care (POC)
high-sensitivity cardiac troponin I (hs-cTnI) assay for myocardial infarction (MI) compared to …

Background Cardiac perforation during leadless pacemaker implantation is more likely to
require intervention than perforation by a transvenous lead. This study reports the …

Background In-hospital mortality in patients with ST-segment elevation myocardial infarction
(STEMI) is higher in those with COVID-19 than in those without COVID-19. The factors that …

Background Our study addressed the diagnostic performance of the Atellica® IM High-Sensitivity
Troponin I (hs-cTnI) assay for the rapid rule-out of myocardial infarction (MI) using a …

Cardiovascular disease (CVD) is the leading cause of maternal death in the United States,
responsible for> 33% of all pregnancy-related deaths. 1 Conditions that emerge during …

There is evidence for late subclinical cardiac dysfunction after a single TS event. 4 Patients
with multiple TS events might be vulnerable to late cardiac dysfunction, although this …